The RheumNow faculty reporters have been glued to their monitors all day, viewing video, reading and listening to abstract presentations and I charged them to earmark those presentations were the “Best” they saw today. Below is the list of most often noted #ACRbest abstracts from Day 1.
All News
Article
Stefan Siebert
Tweet
Our paper on body composition in #PsoriaticArthritis #PsA is now published in @RheumJnl
Results show increased visceral fat in PsA similar to type 2 diabetes in @uk_biobank
Important implications for management.
@iiiglasgow @UofGICAMS @AMRAMedical
https://t.co/6vfkz78tzC
Erin Taylor
Tweet
BSR Guidelines and best practice is the top member benefit and reason for joining @RheumatologyUK. For anyone who wants to know more about how to get involved with guideline development, this is the perfect opportunity. #MemberEngagement https://t.co/SbskxCzkmI
Newly discovered HGF & HGFAC genes differentiate PsA and PsO in genetic analysis. Could these be important additional biomarkers for dz? #ABS0500 #ACR20 #ACRbest @RheumNow https://t.co/TNEQo6d6mk https://t.co/bQFBzYmV0J
sheila
Tweet
ACPA+ and subclinical synovitis does not automatically mean developing to RA.
Interesting work by Cleo Rogier et al. Something to consider in pts w/arthralgias & when to start csDMARDs @RheumNow #ACR20 Abstr#481 #ACRbest https://t.co/q3vIITmtq2
CreakyJoints.org
Tweet
Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time in 43% of patients, found an #ACR20 study from @joannamarco @GGRheumdoc + @UW @uofcincy colleagues. “Close monitoring is warranted” to make sure lung function is not declining. https://t.co/MpA0Rq2uVR
LiSa
Tweet
Timezones wont stop international attendees to make #rheum for knowledge at #ACR20. Watch to see @RHEUMarampa @RichardPAConway @drdavidliew interview @DrSwamyV 🌎🌍🌏
@RheumNow https://t.co/dbIjiLhUnh
David Liew
Tweet
#ACR20 has a fantastic virtual platform & have put in a big effort to make the meeting friendly for international attendees.
I had a great chat about it with @DrSwamyV (@ACRheum Chair, Education) @RheumNow with @RichardPAConway @RHEUMarampa
Check it out: https://t.co/TDHg0PExBC
KenWarringtonMD
Tweet
This convinces me! #TNF inhibitors vs #JAKI
great debate at #ACR20 https://t.co/Xb8KkmDJ8f
Dr. Antoni Chan
Tweet
New treatments in Axial Spa at #ACR20. A significantly higher proportion of pts receiving Upadactinib vs placebo achieved reductions in all PGA of pain assessments and sustained to week 64 @RheumNow Abstr#369
Dr. Antoni Chan
Tweet
Secukinumab has been used to treat spinal involvement in axial SpA. Secukinumab led to significant improvements in symptoms of peripheral arthritis in pts with AS. Significant improvements were seen in both tender and swollen joints @RheumNow #ACR20 Abstr#366
Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman @JointMD
Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis.
https://t.co/VwrQgirJnE
Dr Sarah Mackie
Tweet
@drdavidliew @MGHrheumatology @RheumNow That is so interesting. Haptoglobin first described by Paolaggi et al in early 1980s as having potential to monitor PMR/GCA even when ESR normalised. See link here...
https://t.co/ERkhUwssox
David Liew
Tweet
If TCZ blunts CRP a lot/ESR a fair bit, how can we pick GCA relapses in pts on TCZ?
Cool tech (mass spec w tandem mass tag multiplex) on GiACTA samples. Of 344 candidate proteins, guess what ranked highest?
Haptoglobin.
Let's validate!
@MGHrheumatology #ACR20 ABST0513 @RheumNow https://t.co/ErmqZuf2iu
David Liew
Tweet
@LCalabreseDO @cappelliMD @MarieKostine @EladSharonMD @rheum_covid For those who missed it, my attempt to capture some of it in a Twitter thread: https://t.co/Z55sV7ZyBt
Tailoring treatment of psoriatic arthritis
#ACR20 @RheumNow
https://t.co/Ytv0vDrd95
Check out my video on @rheumnow! #ACR20 Non-radiographic axSpa ACR Abstracts: Dr. Rachel Tate https://t.co/TVDdyZvOEA via @YouTube
Leonard Calabrese
Tweet
Important study helping dissect the JAK-IFN axis I believe - we need to be cautious in attacking this axis as anifrolumab has >2x Zoster of JAKi's- we need to read the tea leaves from IEIs and COVID-19 #ACR20 @JYazdanyMD @Lupusdoc @casanova_lab @cannalab1 https://t.co/scI13jwFZd
Meral K. El Ramahi, MD
Tweet
Abst#0170 at #ACR20 used a process called design thinking (adopted from engineering) to build a comprehensive decision aid that takes into account preferences of both patients & providers. The future of shared-decision making? @RheumNow https://t.co/DDIqm6SQev
Axial Involvement in Psoriatic Arthritis: Perspective by Dr. Eric Ruderman @JointMD
Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis.
https://t.co/VwrQgirJnE


